Princess Margaret Hospital
Haematology Transfusion Medicine Protocols
Please note the Protocols are in PDF format and require Adobe Reader. Please visit our File Formats page if you require further information.
Disclaimer
The Transfusion Guidelines presented on this site are for use within Princess Margaret Hospital for Children. The guidelines are based on the National and International Blood Transfusion Guidelines and are intended to promote better and safer Transfusion Practice.
Transfusion Guidelines
1. Prescribing Blood Components
1.1 The Prescription of Blood Components
1.4 Clinical Indications For Blood Products
2. Requests for Pre Transfusion Testing
2.1 Completion of PathWest Transfusion Request Form
2.2 Collection of Pre Transfusion Samples
2.3 Correct Patient Identification During Sample Collection
2.7 The Role of the Group and Hold Request
2.8 Pre Transfusion Testing for Neonates
2.9 Maximum Surgical Blood Order Schedule (MSBOS)
3. Urgent and Emergency Blood Transfusion Requests
3.1 Urgent Blood Transfusion Requests
3.2 Emergency Uncrossmatched Blood
3.3 PMH Emergency O Rh D Negative Blood for Out of Hours Use
3.4 PMH Massive Transfusion Guideline
3.5 KEMH Massive Transfusion Guideline
4. Issue of Blood Components During Normal Working Hours
4.2 Collection of Blood Components from the Blood Bank
4.3 Issue Via The Vacuum Transport System
4.4 Storage of Blood Outside the Blood Bank
5. PMH Only: The Issue Of Blood Components from the PMH Blood Bank Outside Normal Hours
5.1 General Considerations for Blood Issue at PMH
5.3 Emergency O Rh D Negative Red Cells
6. PMH Only: The Issue Of Blood Components from the KEMH Blood Bank Outside Normal Hours
6.1 General Considerations for Issue of Blood Components
7. Receipt of Blood Components at the Bedside
7.1 General Considerations for Receipt of Blood Products
8. Pre Transfusion Bedside Checks
8.1 Pre Transfusion Checking Procedure
9. Administration of Blood Components
9.1 Standard Administration Checks and Filters
9.6 Calculating a Blood Transfusion Rate
10. Care and Monitoring of Transfused Patients
10.1 Care and Monitoring of Transfused Patients
11. Documenting the Transfusion
12. The Management and Reporting of Adverse Events
12.1 General Considerations in Adverse Events
12.2 Acute Transfusion Reactions
12.3 Delayed Haemolytic Transfusion Reactions
12.4 Other Delayed Complications
13. Fresh Blood Components
13.2 Paediatric Red Blood Cells
13.3 Platelets Single Donor Apheresis
13.6 Special Requirements for Blood Products
14. Plasma Derived Blood Components & Synthetic/Recombinant Products
14.1 Overview of Plasma Derived Blood Components
14.7 Prothrombinex Factors II IX and X
14.11 Hepatitis B immunoglobulin
14.13 Intravenous Tetanus Immunoglobulin
15. Anti D Immunoglobulin
15.1 Fetal Maternal Haemorrhage and Post Partum Complications
15.3 Anti D Immunoglobulin Products and Applications
16. Autologous Pre Deposit Blood Donation
16.1 General Considerations and Risks of Autologous Blood
16.2 Procedure for Autologous Blood Request
17. Intraoperative Cell Salvage
17.1 General Considerations of Intra Operative Cell Salvage
18. PMH and KEMH Directed Donation Policy
18.1 General Information for Clinicians
18.3 Informed Consent in Directed Donation
18.4 ARCBS Donor Selection Criteria
18.5 Directed Donation Procedure
19. PMH and KEMH Policy for the Use of Recombinant Factor VIIa for Life Threatening Bleeding in Medical, Surgical or Trauma Patients
19.1 Background - Recombinant Factor VIIa
19.2 Guidelines for use of Recombinant Factor VIIa
20. Receiving Blood With a Patient Transfer
20.1 Procedure for Receiving Blood
21. References
